Skip to main content

Aptevo Therapeutics Inc.

APVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001671584

No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.

Members of Congress who traded APVO

No member of Congress has reported a trade in Aptevo Therapeutics Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.